CMPD.OB .53
B: CompuMed, Inc. Announces New California Statewide Contract for ECG Services (
BusinessWire )
LOS ANGELES, Oct 08, 2007 (BUSINESS WIRE) --
CompuMed, Inc. (OTCBB:CMPD) -- which operates one of the largest
networks of tele-cardiology systems for remote analytics -- today
announced that it has been awarded a contract by the California
Department of Corrections (CDC) to provide ECG services and cardiology
over-reads for correctional facilities statewide.
Under the agreement, CompuMed will provide its CardioGram ECG
machines and over-read services, which will link CDC facilities with
CompuMed's network of cardiologists. This will enable the CDC to cost
effectively provide a high standard of care to its patients, with
minimal impact to workflow and without requiring patients to be
transported to outside facilities.
"The quality of care provided by correctional facilities is a
burning issue for healthcare providers," said CompuMed CEO Maurizio
Vecchione. "CompuMed is in a position to help correctional facilities
provide the highest standard of care when it comes to cardiology
services, while at the same time reducing their liability
significantly. The CDC contract provides us with a platform for
expanding our installed base in California and follows an upgrade of
our service platform that included an expansion of our cardiology
provider network and improved quality of service."
CompuMed's CardioGram system reduces healthcare costs
significantly by providing remote cardiac screening at the point of
care. Key advantages include a feature that automatically sends ECG
results to a trained cardiologist for an over-read when the results
are abnormal, as well as the ability to store data for Electronic
Medical Records purposes.
About CompuMed:
CompuMed, Inc. (OTCBB:CMPD) develops and markets products and
services that combine advanced imaging with medical informatics. Its
focus is on analysis and remote monitoring for patients with
cardiovascular and musculoskeletal diseases. The Company has
specialized expertise and intellectual property in telemonitoring
imaging and analysis designed to improve healthcare provider workflow
and patient care while reducing costs. CompuMed's core products, the
OsteoGram(R) and CardioGram(TM), are cleared by the FDA and
reimbursable by Medicare. The OsteoGram is a non-invasive diagnostic
system that has been proven by many clinical studies to provide
effective and accurate bone density measurement for screening
osteoporosis and assessing hip fracture risk. The OsteoGram has
significant cost advantages over other technologies in the
marketplace. The CardioGram system is one of the first
telecommunication networks designed to remotely interpret
electrocardiograms and is used by private practice, as well as
government and corporate healthcare providers nationwide. The
CardioGram delivers online electrocardiogram interpretations within
minutes of receipt and has the additional capability of automatically
providing an over-read (i.e., follow-up review) by a cardiologist.
CompuMed is headquartered in Los Angeles and distributes its products
worldwide both directly and through OEM partners. Visit CompuMed
on-line at www.compumed.net. |
